{
    "id": 8144,
    "fullName": "CYP19A1 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "CYP19A1 over exp indicates an over expression of the Cyp19a1 protein. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 1588,
        "geneSymbol": "CYP19A1",
        "terms": [
            "CYP19A1",
            "ARO",
            "ARO1",
            "CPV1",
            "CYAR",
            "CYP19",
            "CYPXIX",
            "P-450AROM"
        ]
    },
    "variant": "over exp",
    "createDate": "06/23/2015",
    "updateDate": "11/29/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2465,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transgenic mouse models over expressing CYP19A1 demonstrated a decrease in neoplastic activity and a reduction in estrogen receptor levels when treated with Femara (letrozole) (PMID: 10731124).",
            "molecularProfile": {
                "id": 8034,
                "profileName": "CYP19A1 over exp"
            },
            "therapy": {
                "id": 794,
                "therapyName": "Letrozole",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3116,
                    "pubMedId": 10731124,
                    "title": "Aromatase overexpression and breast hyperplasia, an in vivo model--continued overexpression of aromatase is sufficient to maintain hyperplasia without circulating estrogens, and aromatase inhibitors abrogate these preneoplastic changes in mammary glands.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/10731124"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 8034,
            "profileName": "CYP19A1 over exp",
            "profileTreatmentApproaches": [
                {
                    "id": 5805,
                    "name": "Aromatase Inhibitor",
                    "profileName": "CYP19A1 over exp"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}